Mobilization of HSCs, a significant increase of immune and progenitor cells in the periphery that are able to migrate into the tumor and the selective targeting of Treg cells in the tumor lesion provide the rationale for an increased anti-tumor immune response upon CXCR4 inhibition. The gene discussed is CXCR4; the disease is neoplasm.